Powered by Inovação Unicamp
Home    
REGISTER HERE
Receive in your email
address the new articles on
the Pipe/Fapesp program.
Name:
e-mail:
City:
Published on March 10, 2008

 

 

BCS Tecnologia
Pressure valve for ICUs is the bet of the company that wants
10% of the market in the first year after launching its product

Rachel Bueno

BCS Tecnologia has two characteristics that are not frequently seen together: at the same time it’s a family business and an innovating enterprise. Its owners, Flávio, Rogério and Cristiane, share their last name Ulbrich – Flávio is Rogério’s brother and Cristiane’s husband – and an enterprising spirit. Between January and August of 2005, they identified a niche to be explored in the market of medical equipment, developed a valve that regulates pressure with innovating characteristics for hospitals, deposited a patent request for it at Brazil’s National Institute of Intellectual Property (Instituto Nacional da Propriedade Industrial, INPI), opened BCS and registered it in the selection process for the State University of Campinas’ Incubator of Knowledge-Based Companies (Incubadora de Empresas da Unicamp, Incamp).

BCS was admitted at Incamp in September of 2005. Since then, the company has concluded a project in Phase II of the Programa Inovação Tecnológica em Pequenas Empresas (Technological Innovation in Small Businesses Program, PIPE) – the program of the State of São Paulo Research Foundation (Fundação de Amparo à Pesquisa do Estado de São Paulo, Fapesp) that gives support to research in small companies – and came in fourth place in the competition Empreender é Show (enterprising is a show), conducted by the National Association of Entities that Foster Innovative Enterprises(Associação Nacional de Entidades Promotoras de Empreendimentos Inovadores, Anprotec) during 2007. For 2008 a lot of work is planned: BCS has already two research projects approved by fostering agencies and is waiting for the approval of three others – two of them through PIPE.

One of the projects waiting for approval from PIPE is running for the edict Fapesp launched in July of 2007 along with the venture capital firm Imprimatur to finance the program’s Phase III. The aim of this project is to carry out tests with the pressure regulating valve directly in hospitals. If Fapesp accepts it BCS may even get Imprimatur as a partner. The other project, submitted last October, is for the program’s Phase I. With it the company wants to investigate if a medical device “for emergency situations” is viable – this is a project of which Cristiane won’t give details. The only thing she tells at this point is that the micro-electronic part of the equipment will be funded by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development, CNPq). The project CNPq has approved includes a visiting researcher.

Complementary competences

The chance to have their own business came up for Flávio, Rogério and Cristiane in January of 2005. It was then that Rogério, a mechanical engineer with a degree from the University of Mogi das Cruzes (Universidade de Mogi das Cruzes, UMC), mentioned to his brother and sister-in-law a fact that had caught his attention in his work in the commercial area of a distributor of medical equipment: each time he visited hospitals and clinics he’d see boxes full of damaged pressure controlling valves. Widely used in Intensive Care Units to control the flow of pure gases or gas mixtures that have direct contact with the patient’s body in diagnoses, treatments or prophylaxis – the so-called medicinal gases, such as oxygen, carbon dioxide and helium, for instance –, these valves were fragile and broke down easily; besides, the health team had a hard time to deal with the mechanism that regulated the pressure.

“We decided to sit down once a week to discuss the problem and try to give it a technical solution,” says Cristiane. “By June we had already developed the product and had a prototype of it,” she adds. With a degree in Mechanical Technology from the Faculdade de Tecnologia de São Paulo (São Paulo School of Technology, Fatec-SP), she has an executive MBA from Ibmec São Paulo and a Master’s Degree and a PhD in Mechanical Engineering from Unicamp, where she is currently doing her post-doc. Cristiane is in charge of BCS’ research and development activities. But she makes a point in highlighting the importance of her brother-in-law’s and her husband’s work. Flávio is a business administrator with specialization in Clinical Engineering from Unicamp’s School of Electrical and Computing Engineering (Faculdade de Engenharia Elétrica e de Computação, FEEC). Clinical engineers manage the use of medical equipment in hospitals. “We have complementary competences,” she points out. Currently the three comprise the company’s staff.

The valve

The valve BCS’ owners have developed has two differentials: protection against falls and a fast shutting system. “When the user removed a valve from the wall, he/she held it from the hose [that takes the medicinal gases to the patient]; that’s when the valve would fall on the floor and break,” says Cristiane, explaining why Rogério saw so many boxes of broken valves in the hospitals he visited. The solution was the development of a rubber protection to reduce the impact on the equipment should it fall down. The shutting system, on the other hand, has the advantage of being automatic. According to Cristiane, in the models available in the market today, the person in charge of shutting them is a hospital staff member. The patent the company has deposited in INPI protects precisely the fast shutting system and the protection against falls.

PIPE

Flávio, Rogério and Cristiane were admitted in Incamp thanks to the valve’s project, but didn’t have the resources to turn the idea into a product. The answer came in the incubator, where they learned how PIPE works. “We had already had contact with a company funded by PIPE, but we thought it wasn’t for us,” she recalls. So they submitted a project to Fapesp. Approved directly to the program’s Phase II, the project was carried out between May of 2006 and May of 2007.

“The objective of Phase II was to conduct experiments with the equipment in order to see if it worked,” sums up Cristiane. She recalls that the first prototype of the valve, manufactured before BCS was created, had the whole engineering of the project, but was never tested with medicinal gases. The company won’t disclose how much Fapesp has given it so far. In the overview of the project submitted to the fostering agency, BCS requested funds to manufacture and test 150 pressure valves.

The tests

BCS has hired Mecatron, a junior company of the course of Control and Automation Engineering of Unicamp’s School of Mechanical Engineering (Faculdade de Engenharia Mecânica, FEM), to conduct the tests with the valve. The undergraduate student David de Jesus Santos, in charge of the project’s management at Mecatron, says that the tests were aimed at verifying if the valve complied with the norms of Brazil’s National Sanitary Surveillance Agency (Agência Nacional de Vigilância Sanitária, Anvisa) for use in hospitals. He invited a PhD candidate from FEM advised by professor Kamal Abdel Radi Ismail to take charge of the technical part of the tests. In four days, three kinds of tests were carried out at FEM’s Laboratory of Thermos and Fluids (Laboratório de Térmica e Fluidos): impact resistance, to evaluate the valve’s protection against falls; performance and functionality, to analyze the product’s durability; and flux characteristics, to check pressure level of gases in and out of the device. According to Santos, who is no longer at Mecatron, the valve got good results in most items, but not in all of them – something which, he says, Cristiane was expecting. In spite of that, he believes the evaluation was positive because “it gave feedback to the company so that it could improve the product.”

Market and commercialization

According to a market study BCS has carried out, about 8,000 pressure control valves are sold each month in Brazil. They cost between US$ 31.50 and US$ 250 – imported models can cost up to US$ 500. The company plans to launch its product in the beginning of the second semester of 2008 and wants to grab 10 percent of the market in the first 12 months. Cristiane believes BCS’s valve can not only compete with the imported products in terms of quality, but be cheaper too. The definition of the price, however, depends on the manufacturer that will be chosen. Because it doesn’t have a certification from Anvisa to manufacture medical equipment, BCS needs to have a partnership with a manufacturer that does.

“It took us more than one and a half years to understand why Anvisa can’t approve this building,” she says, referring to the fact that the incubator doesn’t have the infra-structure the agency requires to issue the certification. BCS has already talked with a potential manufacturer, and, with it and the company in which Rogério works (both names are kept secret), has submitted a project to the program for the formation of local productive arrangements (Arranjos Produtivos Locais, APLs) of the Brazilian Innovation Agency/Research and Projects Financing (Financiadora de Estudos e Projetos, Finep) and the Brazilian Service for the Support of Micro and Small Businesses (Serviço Brasileiro de Apoio às Micro e Pequenas Empresas, Sebrae). “If the project doesn’t come through we’ll have to look for an alternative,” says Cristiane. “BCS is a new enterprise and this is going to be its first product to be commercialized, so we won’t be able not to get around the need for a partnership in order to put it in the market.”

Although the problem of manufacturing still has to be solved, BCS is aware that a lot of valves will have to be sold so that it has profits with them. “That’s why we want to export,” she explains. “If we go for the domestic market only we won’t get the volume we need.” Export plans are already outlined: the idea is to start with Argentina, Portugal and Spain, countries in which BCS’ owners know people who could make the first contact with distribution channels. Before that, though, they’ll have to request an international patent for the equipment and get a certification from the European Union.

According to the executive director of the Brazilian Association of Medical, Odontological, Hospital and Laboratory Articles and Equipment Industry (Associação Brasileira da Indústria de Artigos e Equipamentos Médicos, Odontológicos, Hospitalares e de Laboratórios, Abimo), Hely Maestrello, the UE certification “is the passport to export.” To get it companies must comply with the norm ISO 13485, which deals specifically with medical equipment, and then be approved by a foreign certification institution. Maestrello is familiar with BCS, which is a member of Abimo, and also with its pressure control valve. In his opinion, the innovations in the valve are “very important differentials both in Brazil and abroad.” For that reason he believes that the company has a good chance to take part in the program of exports that Abimo has in partnership with Brazil’s Export Fostering Agency (Agência de Promoção de Exportações do Brasil, Apex).

Quick prototyping

BCS is not developing just medical equipment. The company also has two research projects under way in the area of quick prototyping, in which Cristiane is specialized – she studied the theme in her Master’s Degree and PhD. As the name itself indicates, it’s the manufacture of prototypes in a few hours. The technique, which combines software with special prototyping machines, was created to make possible the manufacture of detailed prototypes of industrial parts. A few years ago it got a new application: the manufacture of customized models of human bones and bone prostheses, used by physicians and dentists to plan complex surgeries.

The two BCS projects on quick prototyping involve FEM’s Department of Biomaterials (Departamento de Biomateriais) and investigate the possibility of the technique be used also for manufacturing bone prostheses proper. One is financed by Fapesp and CNPq; the other, just by CNPq. “We’re in the phase of understanding which characteristics a material must have in order to be at the same time bio-compatible and applicable to quick prototyping,” says Cristiane. “In the future we’re going to develop a material that may be used in implementing prostheses.” She thinks the results of this research line should begin to be seen by 2010.

Learning and future

Now that it is about to complete 2 and half years, BCS’s slogan is: planning. “We’ve learned to plan the company’s management and the product’s development,” Cristiane recognizes. She highlights PIPE’s role in the learning process. “It was PIPE that gave us the energy to understand what it is to develop a knowledge-based product. Without it we’d still be in the realm of ideas.” While the project funded by the program was under way BCS created a protocol with ten items to be analyzed before the development of a product begins – among other things, the company checks if the product would be economically viable and if it would be solving a problem. “There were cases in which we thought of a product to develop, but gave up after carrying out a search for patents because there were similar products in the market. Or the opposite: we’d see that the product was good, was innovative, but the market wouldn’t buy more than 1,000 units.”

As for the possibility of having a venture capital company as a partner should it be approved in the Fapesp-Imprimatur edict, BCS still has no clear position. “We’ve conceived two projects to manufacture the valve [the other is Finep’s and Sebrae’s] and both will take us to the same place. We want to have a choice,” says Cristiane. However, she doesn’t deny her pride for having reached the selection’s final stage. “If a renowned company [Imprimatur] is interested in us, the investment in time we’ve made has been already worth it.”

© 2006-2007 - Inovação Unicamp - PIPE/Fapesp | All rights reserved